Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 315,000 shares, an increase of 504.6% from the December 15th total of 52,100 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is […]
Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 2,660,500 shares, a growth of 600.7% from the July 15th total of 379,700 shares. Based on an average trading volume of 900 shares, the short-interest ratio is […]
Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) was the target of a significant increase in short interest in July. As of July 31st, there was short interest totalling 2,660,500 shares, an increase of 600.7% from the July 15th total of 379,700 shares. Based on an average daily trading volume, of 900 shares, the days-to-cover ratio […]
Mesoblast Limited (OTCMKTS:MEOBF – Free Report) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 2,800 shares, a drop of 92.8% from the May 31st total of 38,900 shares. Based on an average daily volume of 3,700 shares, the days-to-cover […]
Mesoblast (OTCMKTS:MEOBF – Get Rating) is one of 390 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Mesoblast to related businesses based on the strength of its risk, dividends, institutional ownership, valuation, profitability, analyst recommendations and earnings. Valuation and Earnings This table compares Mesoblast and its […]